Tacitus Therapeutics Inc. — Form D
Tacitus Therapeutics Inc. of WEST PALM BEACH, FL, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-10. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-01-10
- Form: D
- Accession: 0001567619-20-000851
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Minimum investment: $2K
- Investors: 2
- Date of first sale: 2019-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-357655
Issuer
- Name: Tacitus Therapeutics Inc.
- CIK: 0001799226
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: C/O SUMMER ROAD LLC, WEST PALM BEACH, FL, 33401
- Phone: 332-333-4315
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Carter Cliff | Director | Cambridge, MA |
| Jeffrey Kennedy | Director | Madison, WI |
| Erik Lium | Director | New York, NY |
| Thomas Novak | Director | WEST PALM BEACH, FL |
| Carter Cliff | Executive Officer | Cambridge, MA |
| Jeffrey Kennedy | Executive Officer | Madison, WI |
More